Sabine Hoepner

Bern, BE, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

IL-21/IL-21R signaling renders acute myeloid leukemia stem cells more susceptible to cytarabine treatment and CAR T cell therapy.

IL-21/IL-21R signaling renders acute myeloid leukemia stem cells more susceptible to cytarabine treatment and CAR T cell therapy.

Journal: Cell reports. Medicine

Published: September 11, 2023

Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack.

Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack.

Journal: Cell reports. Medicine

Published: September 15, 2020

Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents.

Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents.

Journal: Nature medicine

Published: April 10, 2019

TNIK signaling imprints CD8+ T cell memory formation early after priming.

TNIK signaling imprints CD8+ T cell memory formation early after priming.

Journal: Nature communications

Published: March 08, 2019

LIGHT/LTβR signaling regulates self-renewal and differentiation of hematopoietic and leukemia stem cells.

LIGHT/LTβR signaling regulates self-renewal and differentiation of hematopoietic and leukemia stem cells.

Journal: Nature communications

Published: December 03, 2018

CD8+ T cells expand stem and progenitor cells in favorable but not adverse risk acute myeloid leukemia.

CD8+ T cells expand stem and progenitor cells in favorable but not adverse risk acute myeloid leukemia.

Journal: Leukemia

Published: November 15, 2018

CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia.

CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia.

Journal: The Journal of experimental medicine

Published: December 24, 2015

Novel Cell-Penetrating Peptide-Based Vaccine Induces Robust CD4+ and CD8+ T Cell-Mediated Antitumor Immunity.

Novel Cell-Penetrating Peptide-Based Vaccine Induces Robust CD4+ and CD8+ T Cell-Mediated Antitumor Immunity.

Journal: Cancer research

Published: October 15, 2014

Getting by with a little help from the right CD4+ T cells.

Getting by with a little help from the right CD4+ T cells.

Journal: Oncoimmunology

Published: July 15, 2013

Synergy between CD8 T cells and Th1 or Th2 polarised CD4 T cells for adoptive immunotherapy of brain tumours.

Synergy between CD8 T cells and Th1 or Th2 polarised CD4 T cells for adoptive immunotherapy of brain tumours.

Journal: PloS one

Published: December 04, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026